In vitro characterization of novel NR2B selective NMDA receptor antagonists
- 31 May 2005
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 46 (6), 453-464
- https://doi.org/10.1016/j.neuint.2004.12.008
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- State‐dependent NMDA receptor antagonism by Ro 8‐4304, a novel NR2B selective, non‐competitive, voltage‐independent antagonistBritish Journal of Pharmacology, 1998
- Generation and Characterisation of Stable Cell Lines Expressing Recombinant Human N‐Methyl‐d‐Aspartate Receptor SubtypesJournal of Neurochemistry, 1996
- LONG-TERM POTENTIATION AND LEARNINGAnnual Review of Psychology, 1996
- Ifenprodil inhibition of the 5-Hydroxytryptamine3 receptorNeuropharmacology, 1995
- Developmental and regional expression in the rat brain and functional properties of four NMDA receptorsNeuron, 1994
- Excitotoxic cell deathJournal of Neurobiology, 1992
- The NMDA Receptor, NMDA Antagonists and Epilepsy TherapyDrugs, 1992
- A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compoundsJournal of Medicinal Chemistry, 1991
- Magnesium gates glutamate-activated channels in mouse central neuronesNature, 1984